Loading quotes...
Forecast
There is no analyst data available for this company.
Discussions in the community
There is no discussion about this asset yet.
Start discussionNews Go to news feed
Japan Tobacco releases quarterly results: analysts expect slight profit and revenue rise
Japan Tobacco will present results for the quarter ended 30 September 2026 on 29 October 2026. Four analysts on average expect earnings of 110.87 JPY per share (+2.61% vs. the prior year) and seven analysts forecast revenue of 1,012.38 billion JPY (+12.55% vs. the prior year). For the current fiscal year, average expectations are 367.08 JPY earnings per share and 3,886.92 billion JPY in revenue. » More on finanzen.net
Japan Tobacco reports strong profit growth in Q1 2026, shares fall
Japan Tobacco reported adjusted operating profit growth of 20.5% for Q1 2026 and a net profit increase of 27.3%, supported by price adjustments, positive currency effects and strong operational performance in its tobacco products business. Revenue rose markedly, with the tobacco segment recording an adjusted operating profit increase of 19.2%, while processed foods helped stabilize results. Despite the numbers, the share fell 2.83% to ¥5,937 as investors cited risks such as declining volumes of combustibles in markets like Russia and geopolitical and regulatory uncertainties. Management emphasized expansion of its reduced-risk product business (Ploom) and its international rollout. » More on de.investing.com
Japan Tobacco approves dividend of 234 JPY for 2025
For fiscal year 2025, Japan Tobacco approved a dividend of 234.00 JPY at the annual general meeting, equal to a total payout of 356.85 billion JPY and an increase in the payout of 20.62% year-on-year. The dividend yield for 2025 is 4.15% (prior year 4.75%); the stock traded at 5,950 JPY on the AGM date and is quoted ex-dividend. FactSet analysts expect an increase to 253.50 JPY for 2026 (expected yield 4.26%), and the five-year price performance is +179.93% (real return including dividends +181.22%). » More on finanzen.net
Japan Tobacco posts record 2025 results thanks to pricing power and RRP growth
Japan Tobacco reported record figures for fiscal 2025: adjusted operating profit (AOP) of 927.5 billion JPY (+24.9%), net profit of 499.1 billion JPY (+188.9%) and revenue of 3,467.7 billion JPY. Drivers included strong pricing power in its combustible tobacco business, margin expansion and accelerated growth in the reduced-risk products (RRP) segment, notably from the Ploom heated tobacco device and the launch of Ploom AURA. The company announced a record dividend of 234 JPY and expects further growth in 2026 (AOP +8.9% at constant exchange rates), and plans about 800 billion JPY of RRP investments for 2026–2028. » More on de.investing.com
Japan Tobacco International expands sales of Ploom tobacco heater in Germany
Japan Tobacco International will significantly expand the distribution area of its Ploom tobacco heater and Evo tobacco sticks starting next year. Since spring 2024 the product had been available only online and in tobacco shops in the Rhineland (Bonn/Cologne/Düsseldorf); an improved model is now available. JTI aims to establish Ploom and Evo as permanent market players as the market for tobacco heaters in Germany picks up again. » More on faz.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | September 2026 | YoY |
|---|---|---|
| Revenue | 5.63bn | 8.77% |
| Gross profit | 3.31bn | 13.99% |
| Net profit | 1.05bn | 5.11% |
| EBITDA | 1.91bn | 4.74% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €60.74bn |
Number of shares | 1.78bn |
52-week high/low | €44.40 - €29.72 |
Dividend yield | 4.31% |
Dividends TTM | €1.44 |
Beta | 0.13 |
P/E ratio | 17.22 |
PEG ratio | 0.12 |
P/B ratio | 2.58 |
P/S ratio | 2.78 |
Company profile
Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, prescription drugs, and processed foods in Japan and internationally. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products under the Winston, Camel, MEVIUS, Seven Stars, Natural American Spirit, and LD brands. The company also provides reduced-risk products, including tobacco-infused vapor and heated tobacco products, E-Vapor products, etc. under the Ploom, Logic, Ploom TECH, Ploom TECH+, and Ploom S brands. In addition, it researches and develops, manufactures, and sells prescription drugs in the fields of metabolic, viral infection, and autoimmune/inflammatory diseases. Further, the company provides staple food products, such as frozen noodles and okonomiyaki, frozen and packed cooked rice, and frozen baked bread; ambient processed foods; bakery products; and seasonings, including yeast extracts and oyster sauce. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
| Name | Japan Tobacco International |
| CEO | Takehiko Tsutsui |
| Headquarters | Tokyo,
ty Japan |
| Website | |
| Sector | Consumer Staples |
| Industry | Tobacco |
| IPO | 27/01/2011 |
| Employees | 52,867 |
Ticker symbols
| Exchange | Symbol |
|---|---|
Japan Exchange Group | 2914.T |
Pnk | JAPAF |
Frankfurt | JAT.F |
Düsseldorf | JAT.DU |
München | JAT.MU |
Wien | JAT.VI |